Correction: Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. Yu F, Li L, Zhang M, Sun S, et al. BMC Cancer 2023;23:1176.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu F, Li L, Zhang M, Sun S, et al. Correction: Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. BMC Cancer 2023;23:1176.
PMID: 38041002